Free Trial
→ SpaceX eyes a 1.75 trillion valuation - here's what to know (From Brownstone Research) (Ad)tc pixel Free UPHL Stock Alerts

UpHealth (UPHL) Competitors

Compare

UPHL vs. BTTX, ACONW, AONC, DHACW, and LFMDP

Should you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Better Therapeutics (BTTX), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), and LifeMD (LFMDP). These companies are all part of the "healthcare" industry.

How does UpHealth compare to Better Therapeutics?

Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Better Therapeutics has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.

Better Therapeutics has higher earnings, but lower revenue than UpHealth. Better Therapeutics is trading at a lower price-to-earnings ratio than UpHealth, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Better TherapeuticsN/AN/A-$39.76M-$0.78N/A
UpHealth$130M0.00-$56.42M$1.47N/A

In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Better Therapeutics Neutral
UpHealth Neutral

34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by company insiders. Comparatively, 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
Better TherapeuticsN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Better Therapeutics on 4 of the 7 factors compared between the two stocks.

How does UpHealth compare to Aclarion?

Aclarion (NASDAQ:ACONW) and UpHealth (NYSE:UPHL) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, profitability, risk and institutional ownership.

Aclarion has higher earnings, but lower revenue than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aclarion$75.73KN/AN/AN/AN/A
UpHealth$130M0.00-$56.42M$1.47N/A

In the previous week, Aclarion's average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score.

Company Overall Sentiment
Aclarion Neutral
UpHealth Neutral

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AclarionN/A N/A N/A
UpHealth N/A N/A N/A

Summary

UpHealth beats Aclarion on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to American Oncology Network?

UpHealth (NYSE:UPHL) and American Oncology Network (NASDAQ:AONC) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

American Oncology Network has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.47N/A
American Oncology Network$1.34BN/AN/AN/AN/A

In the previous week, American Oncology Network had 3 more articles in the media than UpHealth. MarketBeat recorded 3 mentions for American Oncology Network and 0 mentions for UpHealth. American Oncology Network's average media sentiment score of 0.13 beat UpHealth's score of 0.00 indicating that American Oncology Network is being referred to more favorably in the news media.

Company Overall Sentiment
UpHealth Neutral
American Oncology Network Neutral

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
American Oncology Network N/A N/A N/A

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

American Oncology Network beats UpHealth on 3 of the 5 factors compared between the two stocks.

How does UpHealth compare to Digital Health Acquisition?

UpHealth (NYSE:UPHL) and Digital Health Acquisition (NASDAQ:DHACW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
Digital Health Acquisition N/A N/A N/A

56.1% of UpHealth shares are owned by institutional investors. 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Digital Health Acquisition has lower revenue, but higher earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.47N/A
Digital Health AcquisitionN/AN/AN/AN/AN/A

In the previous week, UpHealth's average media sentiment score of 0.00 equaled Digital Health Acquisition'saverage media sentiment score.

Company Overall Sentiment
UpHealth Neutral
Digital Health Acquisition Neutral

Summary

UpHealth beats Digital Health Acquisition on 3 of the 3 factors compared between the two stocks.

How does UpHealth compare to LifeMD?

UpHealth (NYSE:UPHL) and LifeMD (NASDAQ:LFMDP) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
UpHealthN/A N/A N/A
LifeMD N/A N/A N/A

56.1% of UpHealth shares are held by institutional investors. 34.2% of UpHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

LifeMD has higher revenue and earnings than UpHealth.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
UpHealth$130M0.00-$56.42M$1.47N/A
LifeMD$194.06MN/AN/AN/AN/A

In the previous week, UpHealth's average media sentiment score of 0.00 equaled LifeMD'saverage media sentiment score.

Company Overall Sentiment
UpHealth Neutral
LifeMD Neutral

Summary

UpHealth beats LifeMD on 2 of the 3 factors compared between the two stocks.

Get UpHealth News Delivered to You Automatically

Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UPHL vs. The Competition

Export
MetricUpHealthHealth services IndustryMedical SectorNYSE Exchange
Market Cap$2K$2.52M$6.25B$22.85B
Dividend YieldN/AN/A2.74%4.05%
P/E Ratio0.00N/A29.0228.54
Price / SalesN/AN/A497.4324.25
Price / CashN/AN/A43.3025.18
Price / BookN/AN/A9.655.37
Net Income-$56.42M-$39.76M$3.55B$1.07B

UpHealth Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UPHL
UpHealth
N/AN/AN/AN/A$2K$130MN/A1,750
BTTX
Better Therapeutics
N/AN/AN/A-50.0%$4KN/AN/A40
ACONW
Aclarion
N/A$0.03
-8.5%		N/A+1.7%$0.00$75.73KN/A7
AONC
American Oncology Network
N/A$9.25
flat		N/A+37.4%$0.00$1.34BN/A1,520
DHACW
Digital Health Acquisition
N/A$0.05
+23.8%		N/A+49.6%$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:UPHL) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Why I'm NOT Buying the SpaceX IPO (And What I'm Buying Instead)
The media's calling it "the biggest IPO in Wall Street history." But I'm not buying it. Institutions got into ...
Decentralized Masters | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
PH: Do THESE 4 things to your bank account now …
In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...
Weiss Ratings | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
A U.S. Resource Gap Is a National Issue - and Opportunity
America still does not domestically produce one mineral tied to batteries, energy storage, and national defens...
i2i Marketing Group, LLC | Sponsoredtc pixel